[1] 中华医学会肝病学分会,范建高,南月敏,等. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版). 实用肝脏病杂志,2024,27(4):494-510. [2] Li Y, Yang P, Ye J, et al. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis, 2024, 23(1): 117. [3] Dahl K, Friedrichsen M H, Ribel-Madsen R, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel long-acting FGF21 analog zalfermin. Clin Transl Sci, 2025, 18(12): e70435. [4] Ning M, Lu D, Liang D, et al. Single-cell RNA sequencing advances in revealing the development and progression of MASH: the identifications and interactions of non-parenchymal cells.Front Mol Biosci, 2025, 12: 1513993. [5] Huang Y, Xie Y, Zhang Y, et al. Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC. Mol Cancer, 2025, 24(1): 177. [6] Sun D, Guan X, Moran A E, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol, 2022, 40(4): 527-538. [7] Yu W, Li Y, Zhong F, et al. Disease-associated neurotoxic astrocyte markers in Alzheimer disease based on integrative single-nucleus RNA sequencing. Cell Mol Neurobiol, 2024, 44(1): 20. [8] Butler A, Hoffman P, Smibert P, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol, 2018, 36(5): 411-420. [9] Aran D, Looney A P, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol, 2019, 20(2): 163-172. [10] Gribben C, Galanakis V, Calderwood A, et al. Acquisition of epithelial plasticity in human chronic liver disease. Nature, 2024, 630(8015): 166-173. [11] Wickham H. ggplot2. Wiley interdisciplinary reviews: computational statistics, 2011, 3(2): 180-185. [12] Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The innovation, 2021, 2(3):212-217. [13] Osorio D, Zhong Y, Li G, et al. scTenifoldKnk: an efficient virtual knockout tool for gene function predictions via single-cell gene regulatory network perturbation. Patterns, 2022, 3(3):312-316. [14] 刘洋,文彬,何春雨,等. 肝巨噬细胞调控肝星状细胞活化影响肝纤维化的研究进展. 世界科学技术-中医药现代化,2022,24(3):1097-1102. [15] 冒婷,徐铭益,王佳轶. 非酒精性脂肪性肝炎小鼠模型肝组织T淋巴细胞的特征分析. 临床肝胆病杂志,2025,41(3):461-468. [16] Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab, 2024, 36(7): 1439-1455. [17] Wang C M, Bai Q F, Liu Y J, et al. ChREBP mediates metabolic remodeling in FBP1-deficient liver.Am J Physiol Cell Physiol, 2025, 328(4): C1234-C1246. [18] Wang I H, Huang T T, Chen J L, et al. Mevalonate pathway enzyme HMGCS1 contributes to gastric cancer progression. Cancers, 2020, 12(5): 1088. [19] Dong Y, Yu C, Ma N, et al. MicroRNA-379-5p regulates free cholesterol accumulation and relieves diet induced-liver damage in db/db mice via STAT1/HMGCS1 axis. Mol Biomed, 2022, 3(1): 25. [20] Vidal-Trécan T,Jean-Baptiste J, El Khoury T, et al Effectiveness of six international guidelines using fibrosis-4 and fibroscan for risk stratification of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes. Hepatology, 2025,23(12): 2176-2186. |